Changes to the website
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 1 to 25 of about 4876

Next 25
Website Changes
10/20/2016 An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers.
10/09/2016 High response rate in phase I/II paediatric brain cancer trial
10/09/2016 Exclusive: Interview With DelMar Pharmaceutical CEO Jeffrey Bacha
10/09/2016 Darren Daulton Battling Brain Cancer Through Charitable Foundation
10/09/2016 CIK Treatment Extends Progression-free Survival of Glioblastoma Patients by 1.5 Times
10/09/2016 Last chance for NY Islanders Home Opener Fundraiser!
10/06/2016 Veteran With Terminal Brain Cancer Explains Why He’s Against Assisted Suicide
10/05/2016 Tocagen Presents Updated Tumor Response Data for its Cancer-Selective Gene Therapy
10/01/2016 Injecting live virus in brain tumors may fight cancer, study suggests
10/01/2016 Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma.
10/01/2016 Pioneering Studies Apply New Immunologic Insights to Glioblastoma
10/01/2016 Effect of Bevacizumab Plus Temozolomide-Radiotherapy for Newly Diagnosed Glioblastoma with Different MGMT Methylation Status: A Meta-Analysis of Clinical Trials.
09/30/2016 Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Glioblastoma Multiforme
09/28/2016 Glioblastoma: Overview of Disease and Treatment.
09/28/2016 Efficacy and Safety of Treating Glioblastoma With Tumor-Treating Fields Therapy
09/28/2016 The Musella Foundation For Brain Tumor Research and Information, Inc is proud to announce that we partnered with the DIPG Collaborative to award a $100,000 pediatric brain tumor research grant to Dr. Adrian Krainer, of the Cold Spring Harbor Laboratory in NY.
09/26/2016 Orbus Therapeutics Announces Enrollment of First Patient in Phase 3 Trial in Late-Stage Brain Cancer
09/21/2016 The Clinical Implications of Inconsistently Methylated Results from Glioblastoma MGMT Testing by Replicate Methylation-Specific PCR.
09/19/2016 CNS Oncology Publishes Tumor Treating Fields Treatment Planning and Patient Follow-up Guidelines in Glioblastoma
09/19/2016 Brain cancer replaces leukemia as deadliest cancer for kids, study shows
09/13/2016 The CERN Foundation recently completed the second edition of their Ependymoma Guide
09/08/2016 Monteris Medical Receives IDE Approval From FDA To Evaluate NeuroBlate® In Patients Newly Diagnosed With Glioblastoma Multiforme
09/08/2016 Human cytomegalovirus encoded chemokine receptor US28 activates the HIF-1a/PKM2 axis in glioblastoma cells.
09/07/2016 DelMar Pharmaceuticals and Accurexa to Collaborate in the Development of a Novel Combination Chemotherapy for the Local Treatment of Brain Cancer
09/07/2016 NY Islanders fundraiser for Brain Tumor Research!

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2016 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557

Website Design By
World Wide Websites